Search for Companies, Tipsters or Sources…
Companies
Tipsters
Brokers
Sources
Or view the latest share tips
Company Results
Tipster results
Broker results
Sources results
Fund Manager results
Tips from these results
Recent Share tips:
- Buy Lloyds Banking Group (LLOY) by Alan Oscroft in The Motley Fool
- Buy NATWEST GROUP (NWG) by Harvey Jones in The Motley Fool
- Buy Kainos Group (KNOS) by Lucy Tobin in The Times - Tempus
- Buy Legal & General Group (LGEN) by Christopher Ruane in The Motley Fool
- Buy City of London Investment Group (CLIG) by Mark Rogers in The Motley Fool
- Buy Barclays (BARC) by Charlie Keough in The Motley Fool
- Neutral Land Securities Group (LAND) by JP Morgan
- Buy BT Group (BT.A) by Berenberg
- Sell Sage Group (SGE) by Canaccord Genuity
- Buy Secure Trust Bank (STB) by Berenberg
- Speculative Buy Hummingbird Resources (HUM) by Canaccord Genuity
- Hold M&G (MNG) by Berenberg
- Buy FD Technologies Public Limited Company (FDP) by Shore Capital
- Hold Land Securities Group (LAND) by Shore Capital
- Buy Tritax Big Box Reit (BBOX) by Shore Capital
- Buy Devolver Digital, Inc. (DI) Reg S Cat 3/144A (DEVO) by Shore Capital
- Watch Supermarket Income Reit (SUPR) by Jon Smith in The Motley Fool
- Buy Rolls-Royce Holdings (RR.) by Jon Smith in The Motley Fool
- Avoid Proteome Sciences (PRM) by Steve Moore in ShareProphets
- Buy Phoenix Group Holdings (PHNX) by Christopher Ruane in The Motley Fool
Arecor Therapeutics (AREC) Share Price
Health Care Sector
NOTE: This is based on 0 open tips for Arecor Therapeutics (AREC)
| Latest Bid : 127.00p | Latest Ask : 135.00p |
| High Today : 135.00p | Low Today : 127.20p |
| This Years High : 255.00p | This Years Low : 127.20p |
| Volume : 5,777 | MKT Cap : £39.3M |
| Trading Velocity : Premium Only | Activity Score : Premium Only |
| Consensus Score : Premium Only | Momentum Score : Premium Only |
Arecor Therapeutics (AREC) Overview
Arecor is a globally focused biopharmaceutical company that is targeting improving patient care by bringing innovative medicines to market through the enhancement of existing therapeutic products. By applying the Group's innovative proprietary formulation technology platform, Arestat, the Group is developing an internal portfolio of proprietary products, as well as working with pharmaceutical and biotechnology companies to deliver enhanced reformulations of their partners' therapeutic products, supported by an extensive patent portfolio.Arecor Therapeutics (AREC) Active Short Positions
| Fund Manager | Position | Date | ||
|---|---|---|---|---|
| No active short positions | ||||
| Latest Bid : 127.00p | Latest Ask : 135.00p |
| High Today : 135.00p | Low Today : 127.20p |
| This Years High : 255.00p | This Years Low : 127.20p |
| Volume : 5,777 | MKT Cap : £39.3M |
Arecor Therapeutics Overview
Arecor is a globally focused biopharmaceutical company that is targeting improving patient care by bringing innovative medicines to market through the enhancement of existing therapeutic products. By applying the Group's innovative proprietary formulation technology platform, Arestat, the Group is developing an internal portfolio of proprietary products, as well as working with pharmaceutical and biotechnology companies to deliver enhanced reformulations of their partners' therapeutic products, supported by an extensive patent portfolio.NOTE: This description is in part generated by ChatGPT and not an endorsement by or the opinion of Stockomendation Ltd.